According to a new survey, the reputation of the pharmaceutical industry among patient groups has seen a modest increase in the past year.
Despite this improvement, many patient advocates continue to express worries about the accessibility of medications and the high costs associated with them.
These ongoing concerns suggest that while the industry is making strides in reputation, substantial challenges still need to be addressed.